JAAOS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Acad Orthop Surg, Vol 11, No 1, January/February 2003, 6-11.
© 2003 the American Academy of Orthopaedic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wetzel, F. T.
Right arrow Articles by McNally, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wetzel, F. T.
Right arrow Articles by McNally, T. A.

Treatment of Chronic Discogenic Low Back Pain With Intradiskal Electrothermal Therapy

F. Todd Wetzel, MD and Thomas A. McNally, MD

Dr. Wetzel is Associate Professor of Surgery, Section of Orthopaedic Surgery and Rehabilitation Medicine and Anesthesia and Critical Care, University of Chicago Spine Center, Chicago, IL. Dr. McNally is Fellow in Spine Surgery, Section of Orthopaedic Surgery and Rehabilitation Medicine, University of Chicago Spine Center.

Reprint requests: Dr. Wetzel, 4646 North Marine Drive, 8 NW, Chicago, IL 60640.

The treatment of chronic, nonradicular, discogenic low back pain remains controversial. The posterior anulus fibrosus appears to be a potential site of origin of the pain, which is mediated by nociceptors in the inner layers of the anulus. Diagnosis requires a thorough history, physical examination, and imaging protocol; provocative diskography is key. Nonsurgical treatment options have been limited to physical therapy and pharmacotherapy. Success rates of spinal fusion range from 39% to 96%. Reported therapeutic success rates of intradiskal electrothermal therapy, a possible intermediate treatment, range from 60% to 80%. Despite this apparent therapeutic effect, however, a more precise quantification of clinical benefits remains to be proved in randomized prospective trials.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Academy of Orthopaedic Surgeons.